Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 for Prevention of Acute Mountain Sickness
ChiCTR2500108700Phase 4Completed
- Sponsor
- Second People's Hospital of Haibei Tibetan Autonomous Prefecture
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of coenzyme q10 in acute mountain sickness (AMS) (3 arms), sponsored by Second People's Hospital of Haibei Tibetan Autonomous Prefecture. Primary endpoints: Blood oxygen saturation and Lake Louise Questionnaire score. Started Sep 2025; status: completed.
02
Drugs
coenzyme q10
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on ChiCTR2500108700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108700.